IRobot Net Worth
IRobot Net Worth Breakdown | IRBT |
IRobot Net Worth Analysis
IRobot's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including IRobot's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of IRobot's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform IRobot's net worth analysis. One common approach is to calculate IRobot's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares IRobot's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing IRobot's net worth. This approach calculates the present value of IRobot's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of IRobot's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate IRobot's net worth. This involves comparing IRobot's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into IRobot's net worth relative to its peers.
Enterprise Value |
|
To determine if IRobot is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding IRobot's net worth research are outlined below:
| iRobot is way too risky over 90 days horizon | |
| iRobot appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 681.85 M. Net Loss for the year was (145.52 M) with profit before overhead, payroll, taxes, and interest of 551.52 M. | |
| iRobot currently holds about 89.59 M in cash with (33.22 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.28. | |
| Latest headline from globenewswire.com: DEADLINE ALERT for HIMS, IRBT, CNC, BHVN Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions |
IRobot Quarterly Good Will |
|
IRobot uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in iRobot. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to IRobot's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 12th of February 2024 Upcoming Quarterly Report | View | |
| 14th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 12th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Know IRobot's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as IRobot is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading iRobot backward and forwards among themselves. IRobot's institutional investor refers to the entity that pools money to purchase IRobot's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Jpmorgan Chase & Co | 2025-03-31 | 386 K | Mirae Asset Global Etfs Holdings Ltd. | 2025-03-31 | 358.3 K | Bank Of America Corp | 2025-03-31 | 322.7 K | Deutsche Bank Ag | 2025-03-31 | 305.7 K | Graham Capital Management | 2025-03-31 | 296.2 K | Renaissance Technologies Corp | 2025-03-31 | 286.5 K | Northern Trust Corp | 2025-03-31 | 263 K | Quinn Opportunity Partners Llc | 2025-03-31 | 256.9 K | Qube Research & Technologies | 2025-03-31 | 238.3 K | Blackrock Inc | 2025-03-31 | 2.3 M | Vanguard Group Inc | 2025-03-31 | 1.7 M |
Follow IRobot's market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 151.79 M.Market Cap |
|
Project IRobot's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.44) | (0.41) | |
| Return On Capital Employed | (0.45) | (0.42) | |
| Return On Assets | (0.34) | (0.33) | |
| Return On Equity | (0.60) | (0.57) |
When accessing IRobot's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures IRobot's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of IRobot's profitability and make more informed investment decisions.
Please note, the imprecision that can be found in IRobot's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of iRobot. Check IRobot's Beneish M Score to see the likelihood of IRobot's management manipulating its earnings.
Evaluate IRobot's management efficiency
Return On Tangible Assets is likely to gain to -0.41 in 2025. Return On Capital Employed is likely to gain to -0.42 in 2025. At this time, IRobot's Non Current Liabilities Total is comparatively stable compared to the past year. Non Current Liabilities Other is likely to gain to about 26 M in 2025, whereas Liabilities And Stockholders Equity is likely to drop slightly above 482.2 M in 2025. IRobot's management efficiency ratios could be used to measure how well IRobot manages its routine affairs as well as how well it operates its assets and liabilities.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 17.48 | 18.35 | |
| Tangible Book Value Per Share | 10.90 | 6.00 | |
| Enterprise Value Over EBITDA | (5.76) | (5.47) | |
| Price Book Value Ratio | 2.75 | 2.89 | |
| Enterprise Value Multiple | (5.76) | (5.47) | |
| Price Fair Value | 2.75 | 2.89 | |
| Enterprise Value | 377.2 M | 576.7 M |
IRobot's management has consistently demonstrated strong leadership, driving both financial growth and operational excellence. By analyzing current market trends and future growth opportunities, we assess the stock's true value and potential for investors.
Enterprise Value Revenue 0.523 | Revenue | Quarterly Revenue Growth (0.32) | Revenue Per Share | Return On Equity |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific IRobot insiders, such as employees or executives, is commonly permitted as long as it does not rely on IRobot's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases IRobot insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
IRobot time-series forecasting models is one of many IRobot's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary IRobot's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
IRobot Earnings per Share Projection vs Actual
IRobot Corporate Executives
Elected by the shareholders, the IRobot's board of directors comprises two types of representatives: IRobot inside directors who are chosen from within the company, and outside directors, selected externally and held independent of IRobot. The board's role is to monitor IRobot's management team and ensure that shareholders' interests are well served. IRobot's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, IRobot's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Julie Zeiler | Executive CFO | Profile | |
| Alison Dean | CFO, Executive VP and Treasurer | Profile |
Additional Tools for IRobot Stock Analysis
When running IRobot's price analysis, check to measure IRobot's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IRobot is operating at the current time. Most of IRobot's value examination focuses on studying past and present price action to predict the probability of IRobot's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IRobot's price. Additionally, you may evaluate how the addition of IRobot to your portfolios can decrease your overall portfolio volatility.